Evidence of prolonged overall survival using rapamycin as main immunosuppression in patients transplanted for primary hepatocellular carcinoma with extended criteria on pathology
- Publication date
- 1 January 2007
- Publisher
- 'Foundation for Cellular and Molecular Medicine'